445305-93-1

Usage

Uses

Used in Pharmaceutical Industry:
Cyclopropylmethanesulfonamide is utilized as an antimicrobial agent for its ability to combat various microorganisms. Its high reactivity and potential to interact with biological targets make it a valuable component in the development of new drugs to treat infections.
Used in Agrochemical Industry:
In agrochemicals, cyclopropylmethanesulfonamide serves as a biocidal agent, protecting crops from harmful pathogens and pests. Its inclusion in agrochemical products helps to ensure the health and productivity of agricultural yields.
The specific applications and reasons for using cyclopropylmethanesulfonamide in these industries are based on its inherent chemical properties, which include its reactivity, stability, and solubility, all of which contribute to its effectiveness as an antimicrobial agent.

Upstream product

• 114132-26-2 cyclopropylmethanesulfonyl chloride 
• 7051-34-5 cyclopropylcarbinyl bromide 

Relevant academic research and scientific papers

HEPATITIS C VIRUS INHIBITORS

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS

Macrocyclic peptides having the general formula (I): are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS

Macrocyclic peptides having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Hepatitis C virus inhibitors

The present disclosure relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.